Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07813611
Starting soon Observational

Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis

NCT07813611 · tracked via the Priya Life Science Turkey tracker
Sponsor
Istanbul Medeniyet University
Phase
Observational
Started
2026-10
Last updated
2026-09-15

Condition(s) studied

Atopic Dermatitis (AD)ScabiesImpetigo

Study summary

This prospective observational study will evaluate the microbiological profile of secondary bacterial infection and nasal colonization in participants with scabies or atopic dermatitis. Bacteria isolated from impetiginized skin lesions and nasal swabs will be compared, and antimicrobial susceptibility patterns will be assessed. Healthy participants without an inflammatory skin disease or signs of infection will provide nasal swabs as a control group. Patients will be followed on days 7 and 14 to assess clinical response and related clinical measures.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Scabies group: dermatologist-confirmed scabies and an active impetiginized skin lesion. * Atopic dermatitis group: dermatologist-confirmed atopic dermatitis and an active impetiginized skin lesion. * Healthy control group: no inflammatory skin disease or clinical signs of infection. * Written informed consent (and appropriate parent/guardian permission when applicable). Exclusion Criteria: * Systemic or topical antibiotic use within the previous 14 days. * Active nasal infection or nasal symptoms. * History of nasal surgery or anatomic nasal deformity. TEST DRAFT NOTE: The source protocol contains wording that may conflict with inclusion of healthy controls; the final eligibility text must be reconciled with the ethics-approved protocol before release.

Primary outcome measure(s)

  • Concordance of bacterial species between impetiginized skin lesion and nasal cultures — At baseline (enrollment)
    Among participants in the scabies and atopic dermatitis groups with paired evaluable skin and nasal cultures, concordance will be defined as isolation of the same bacterial species from both anatomical sites. Species-level agreement will be summarized and evaluated using Cohen's kappa coefficient.

Trial sites (1)

FacilityCityRegionStatus
Test Study Site - Replace Istanbul Turkey (Türkiye)

More Istanbul Medeniyet University trials in Turkey

Bladder Stimulation Technique for Urine Collection in the Pediatric Emergency Department Active, not recruiting
Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Cord Injury Recruiting
Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study Active, not recruiting
Motivational Interviewing and WhatsApp-Based Monitoring for Metabolic Control and Self-Efficacy in Adolescents With T1DM Starting soon
Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07813611 on ClinicalTrials.gov ↗ ← All trials in Turkey